Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 3
2005 3
2006 1
2007 1
2008 1
2009 1
2010 3
2011 6
2012 3
2013 1
2014 1
2015 1
2016 1
2017 2
2018 2
2019 5
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
Castagnoli L, Cancila V, Cordoba-Romero SL, Faraci S, Talarico G, Belmonte B, Iorio MV, Milani M, Volpari T, Chiodoni C, Hidalgo-Miranda A, Tagliabue E, Tripodo C, Sangaletti S, Di Nicola M, Pupa SM. Castagnoli L, et al. Among authors: pupa sm. Oncogene. 2019 May;38(21):4047-4060. doi: 10.1038/s41388-019-0700-2. Epub 2019 Jan 31. Oncogene. 2019. PMID: 30705400 Free PMC article.
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.
Pietrantonio F, Fucà G, Morano F, Gloghini A, Corso S, Aprile G, Perrone F, De Vita F, Tamborini E, Tomasello G, Gualeni AV, Ongaro E, Busico A, Giommoni E, Volpi CC, Laterza MM, Corallo S, Prisciandaro M, Antista M, Pellegrinelli A, Castagnoli L, Pupa SM, Pruneri G, de Braud F, Giordano S, Cremolini C, Di Bartolomeo M. Pietrantonio F, et al. Among authors: pupa sm. Clin Cancer Res. 2018 Mar 1;24(5):1082-1089. doi: 10.1158/1078-0432.CCR-17-2781. Epub 2017 Dec 5. Clin Cancer Res. 2018. PMID: 29208673 Free article.
The landscape of d16HER2 splice variant expression across HER2-positive cancers.
Volpi CC, Pietrantonio F, Gloghini A, Fucà G, Giordano S, Corso S, Pruneri G, Antista M, Cremolini C, Fasano E, Saggio S, Faraci S, Di Bartolomeo M, de Braud F, Di Nicola M, Tagliabue E, Pupa SM, Castagnoli L. Volpi CC, et al. Sci Rep. 2019 Mar 5;9(1):3545. doi: 10.1038/s41598-019-40310-5. Sci Rep. 2019. PMID: 30837627 Free PMC article.
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment.
Koschorke A, Faraci S, Giani D, Chiodoni C, Iorio E, Canese R, Colombo MP, Lamolinara A, Iezzi M, Ladomery M, Vernieri C, de Braud F, Di Nicola M, Tagliabue E, Castagnoli L, Pupa SM. Koschorke A, et al. Among authors: pupa sm. Cell Oncol (Dordr). 2019 Dec;42(6):815-828. doi: 10.1007/s13402-019-00464-w. Epub 2019 Aug 2. Cell Oncol (Dordr). 2019. PMID: 31376137
HER2 as a target for breast cancer therapy.
Tagliabue E, Balsari A, Campiglio M, Pupa SM. Tagliabue E, et al. Among authors: pupa sm. Expert Opin Biol Ther. 2010 May;10(5):711-24. doi: 10.1517/14712591003689972. Expert Opin Biol Ther. 2010. PMID: 20214497 Review.
Promise and failure of targeted therapy in breast cancer.
Giordano A, Tagliabue E, Pupa SM. Giordano A, et al. Among authors: pupa sm. Front Biosci (Schol Ed). 2012 Jan 1;4:356-74. doi: 10.2741/273. Front Biosci (Schol Ed). 2012. PMID: 22202065 Review.
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page